| FPL | fasting plasma lipids; flexor pollicis longus |
|---|---|
| TL | temporal lobe; terminal limen; thermolabile; thermoluminescence; threat to life; thymus-leukemia [an... |
| RES | Reticulo-Endothelial System |
| ol | res oleoresin |
| RES | radionuclide esophageal scintigraphy; reticuloendothelial system |
| RES | Reserpine |
|---|---|
| RES | Reticulo Endothelial System |
| IMCL | Intra-myocellular lipids |
| SL | Structured lipids |
| POL | peroxide oxidation of lipids |
| RES | <abbreviation> Reticuloendothelial system. (05 Mar 2000) |
|---|---|
| membrane lipids | Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. (12 Dec 1998) |
| compound lipids | Lipids containing N and P atoms in addition to the usual C, H, and O. Compare: homolipids. Synonym: compound lipids. (05 Mar 2000) |
| simple lipids | Lipids containing only C, H, and O. Compare: heterolipids. Synonym: simple lipids. (05 Mar 2000) |
| lipids | Biological molecules soluble in apolar solvents, but only very slightly soluble in water. They are an heterogenous group (being defined only on the basis of solubility) and include fats, waxes and terpenes. (18 Nov 1997) |
| lipids and antilipaemic agents | A collective grouping for lipids and substances that maintain normal blood lipid levels. (12 Dec 1998) |
| anabolic steroids | Any of a group of synthetic derivatives of testosterone, having pronounced anabolic properties and relatively weak androgenic properties, that are used mainly to promote growth and repair body tissues. (12 Dec 1998) |
| steroids | A group of synthetic hormones including prednisone, prednisolone, methylprednisolone and dexamethasone used in the treatment of some leukaemias and also to suppress graft rejection and graft-versus-host disease following bone marrow transplant. Side effects include an increased risk of infection. (13 Nov 1997) |
| steroids, brominated | Steroids which are substituted with one or more bromine atoms in any position. (12 Dec 1998) |
| steroids, chlorinated | Steroids which are substituted with one or more chlorine atoms in any position. (12 Dec 1998) |
| steroids, fluorinated | Steroids which are substituted with one or more fluorine atoms in any position. (12 Dec 1998) |
| steroids, heterocyclic | Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with non-carbon atoms. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|